Brain Tumor Treatment Market Premium Analysis and Global Growth Upto 2025

A brain tumor is an abnormal growth of cells in the tissue of the brain. It can be cancerous (malignant) and non-cancerous (benign). The growth rate of the brain tumor affects the nervous system of the brain. Malignant brain tumor cells contain cancer cells and they do not have any clear border. Their growth rate is very high and invades into other tissues of the brain, which is life threatening. A benign brain tumor originates from the cell of the brain, and its growth rate is limited. It has a clear border and does not spread into other tissues. There are two types of brain tumor: primary brain tumor and secondary brain tumor. The primary brain tumor starts from the brain and may spread to other parts of the brain or spine but rarely spreads to other organs of the body. The secondary brain tumor starts from other part of the body and then spreads to the brain. The secondary brain tumor is more common as compared to the primary brain tumor. Family history, age, race, and exposure to radiation and chemicals are some of the risk factors of the disease. The treatment options depend upon the size and location of the tumor.

Read the Comprehensive Overview of Brain Tumor Treatment Market: http://www.transparencymarketresearch.com/brain-tumor-treatment-market.html

Based on treatment, the global brain tumor treatment market can be segmented into drug therapy and surgery. A brain tumor treatment usually starts with drugs such as everolimus, bevacizumab, and carmustine. Modern surgical equipment allows a surgeon to locate a tumor and remove the tumor. The drug therapy segment is further categorized as chemotherapy and targeted therapy. On the basis of diagnosis, the market is classified as CT scan, PET-CT scan, molecular testing of tumor, cerebral arteriogram, and myelogram. The increase in incidence rate of brain tumor in recent decades is one of the major factors driving the global market. In addition, rise in geriatric population and launch of new drugs for the treatment of brain tumor are other factors that are fueling the growth of the market. However, limited availability of drugs specific to the brain tumor treatment, high cost of therapy and side-effect associated with it, and increase in use of generics in chemotherapy are hampering the growth of the brain tumor treatment market.

Geographically, the global market for brain tumor treatment is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America dominates the global market owing to high incidence rate of brain tumor, improved treatment options, and developed health care infrastructure. In Europe, the European Medicines Agency (EMA) is associated with many pharmaceutical companies to evaluate drugs for the treatment of brain tumor and ensure the protection of public health with proper supervision of these drugs. This factor helps in driving the growth of the Europe market. Asia Pacific is a less mature but an emerging market owing to developing health care infrastructure, growing patient awareness, and increasing government expenditure. In Middle East & Africa, the ongoing clinical trials and established medical support help the market to expand.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25247

Major players operating in the global brain tumor treatment market include Pfizer Inc., Bayer HealthCare Pharmaceuticals Inc., F. Hoffmann-La Roche AG, AstraZeneca plc, Novartis International AG, Merck & Co., and Dr. Reddy’s Laboratories.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.